Growth Metrics

Bioventus (BVS) Total Non-Current Liabilities (2020 - 2026)

Bioventus filings provide 6 years of Total Non-Current Liabilities readings, the most recent being $439.8 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 15.31% to $439.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $439.8 million, a 15.31% decrease, with the full-year FY2025 number at $439.8 million, down 15.31% from a year prior.
  • Total Non-Current Liabilities hit $439.8 million in Q4 2025 for Bioventus, down from $473.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $994.6 million in Q4 2022 to a low of $392.8 million in Q2 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $557.4 million (2024), compared with a mean of $573.0 million.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 152.83% in 2022 and later plummeted 44.33% in 2023.
  • Bioventus' Total Non-Current Liabilities stood at $601.9 million in 2021, then skyrocketed by 56.68% to $943.0 million in 2022, then tumbled by 40.42% to $561.9 million in 2023, then fell by 7.58% to $519.2 million in 2024, then fell by 15.31% to $439.8 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $439.8 million (Q4 2025), $473.9 million (Q3 2025), and $484.2 million (Q2 2025) per Business Quant data.